Emeis Stock Bounces Back 2.5% and Ranks Among Top Gainers in SBF 120
The healthcare services group's stock sees a sharp rise mid-morning, bucking its monthly downtrend. The stock is among the top performers in the SBF 120, in a Parisian market trending upwards following the interim agreement between Washington and Tehran. This movement comes just days before a statutory meeting for the group.
Stock Rebounds to Its Short-Term Moving Averages After a Month of Decline
Emeis stock gains 2.71% to €14.02 in mid-morning trading, up from €13.65 the previous day. The stock is among the strongest gainers in the SBF 120, which itself is up by 0.26%. Over the month, the stock is down by 4.89%, yet it has gained 27.69% over the year. Today's rebound brings the price back to its short-term moving averages, though it does not surpass them. The 20-day moving average at €14.30 and the 50-day moving average at €14.35 remain slightly above the current price, which, however, is above the 200-day moving average at €13.91. The RSI at 38 indicates the recent downtrend phase, without a clear oversold signal. The support level identified at €13.64, close to the previous day's closing price, has held during recent sessions, aligning with the surge observed this morning.
A Bullish Session Ahead of the General Meeting on June 23
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The healthcare services group is holding its annual general meeting on June 23, the next milestone on its financial calendar. The stock had lost ground at the beginning of June while testing a technical support, a sequence to which today's rebound provides an initial response. The market context is favorable at the end of this week. The CAC 40 is up by 0.28% at 8,492 points and the VIX is down by 8.46% at 16.88, following the interim agreement signed on June 18 between the United States and Iran, which immediately eased crude oil prices. The next significant financial milestone will be crossing the €14.30-€14.35 zone, where the two short-term moving averages converge.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.